Detalhe da pesquisa
1.
Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
Pediatr Blood Cancer
; 69(12): e29986, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151978
2.
Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population.
Support Care Cancer
; 30(4): 3513-3520, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018520
3.
Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials.
Cancer
; 127(19): 3664-3670, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196962
4.
Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.
Cancer
; 127(9): 1483-1494, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332590
5.
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
Cancer
; 126(1): 140-147, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553494
6.
Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.
Pediatr Blood Cancer
; 67(4): e28160, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31904157
7.
A Pediatric Case of Transformed Mycosis Fungoides in a BRCA2 Positive Patient.
J Pediatr Hematol Oncol
; 42(5): e361-e364, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969264
8.
PROMIS pediatric measures validated in a longitudinal study design in pediatric oncology.
Pediatr Blood Cancer
; 66(5): e27606, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663254
9.
Capturing the young child's reports of cancer treatment tolerability: Does our practice reflect an assumption that they cannot report?
Pediatr Blood Cancer
; 70(1): e30028, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250991
10.
Profiles of Symptom Suffering and Functioning in Children and Adolescents Receiving Chemotherapy.
Cancer Nurs
; 46(2): E129-E137, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816032
11.
Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy.
JAMA Netw Open
; 5(3): e221855, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348712
12.
Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.
J Clin Oncol
; 40(15): 1623-1634, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294262
13.
Subjective Toxicity Profiles of Children in Treatment for Cancer: A New Guide to Supportive Care?
J Pain Symptom Manage
; 61(6): 1188-1195.e2, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33096220
14.
Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment.
JAMA Pediatr
; 174(11): e202861, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32832975
15.
Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
J Natl Cancer Inst
; 112(11): 1143-1152, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999349
16.
Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
Clin Cancer Res
; 11(4): 1669-74, 2005 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15746072
17.
Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients.
Children (Basel)
; 1(3): 424-40, 2014 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27417488
18.
Feasibility and acceptability of the patient-reported outcomes measurement information system measures in children and adolescents in active cancer treatment and survivorship.
Cancer Nurs
; 37(1): 66-74, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24036439
19.
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Pediatr Blood Cancer
; 49(3): 250-5, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16856155